{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:24:17Z","timestamp":1793618657394,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jceh.2023.08.013","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T04:15:53Z","timestamp":1694232953000},"page":"101277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Independent Association of Non-alcoholic Fatty Liver Disease With Incident Cardiovascular Disease: A GRADE Evaluation of the Evidence Through a Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"14","author":[{"given":"Manya","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunanda","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv K.","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2023.08.013_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.08.013_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.08.013_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2023.08.013_bib4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hep.31608","article-title":"Hepatic fibrosis ASSOCIATES WITH MULTIPLE cardiometabolic disease risk factors: the Framingham Heart study","volume":"73","author":"Long","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.08.013_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.atherosclerosis.2013.01.013","article-title":"Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease","volume":"227","author":"Feitosa","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jceh.2023.08.013_bib6","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.3748\/wjg.v20.i26.8407","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease","volume":"20","author":"Liu","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.08.013_bib7","doi-asserted-by":"crossref","first-page":"d6891","DOI":"10.1136\/bmj.d6891","article-title":"Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study","volume":"343","author":"Lazo","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2023.08.013_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MEG.0000000000000254","article-title":"Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease","volume":"27","author":"Luo","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.08.013_bib9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2013.07.052","article-title":"A\u00a0systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?","volume":"230","author":"Oni","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jceh.2023.08.013_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.jceh.2023.08.013_bib11","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2023.08.013_bib12","unstructured":"Tool to Assess Risk of Bias in Cohort Studies.pdf [Internet]. [cited 2020 May 29]. Available from: https:\/\/methods.cochrane.org\/sites\/methods.cochrane.org.bias\/files\/public\/uploads\/Tool%20to%20Assess%20Risk%20of%20Bias%20in%20Cohort%20Studies.pdf."},{"key":"10.1016\/j.jceh.2023.08.013_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jceh.2023.08.013_bib14","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ajg.2010.18","article-title":"Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study","volume":"105","author":"Adams","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.08.013_bib15","doi-asserted-by":"crossref","first-page":"l5367","DOI":"10.1136\/bmj.l5367","article-title":"Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults","volume":"367","author":"Alexander","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2023.08.013_bib16","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.29546","article-title":"Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year-community study","volume":"67","author":"Allen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.08.013_bib17","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cgh.2019.12.026","article-title":"Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study","volume":"18","author":"Baratta","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.08.013_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ndt\/gfx381","article-title":"Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease","volume":"34","author":"Chinnadurai","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jceh.2023.08.013_bib19","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.08.013_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jsha.2013.07.004","article-title":"Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events","volume":"25","author":"El Azeem","year":"2013","journal-title":"J\u00a0Saudi Heart Assoc"},{"key":"10.1016\/j.jceh.2023.08.013_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2016.01.016","article-title":"Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up","volume":"246","author":"Fracanzani","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jceh.2023.08.013_bib22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4254\/wjh.v12.i7.378","article-title":"Non-alcoholic steatohepatitis and the risk of myocardial infarction: a population-based national study","volume":"12","author":"Ghoneim","year":"2020","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2023.08.013_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/liv.13973","article-title":"Cardiovascular risk factors in non-alcoholic fatty liver disease","volume":"39","author":"Hagstr\u00f6m","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2023.08.013_bib24","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3748\/wjg.v13.i10.1579","article-title":"Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease","volume":"13","author":"Hamaguchi","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.08.013_bib25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/hep.23135","article-title":"Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels","volume":"50","author":"Haring","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.08.013_bib26","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.cgh.2017.11.026","article-title":"Nonalcoholic fatty liver disease associates with increased overall mortality and death from cancer, cardiovascular disease, and liver disease in women but not men","volume":"16","author":"Hwang","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.08.013_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12933-020-01192-4","article-title":"Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study","volume":"20","author":"Ichikawa","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jceh.2023.08.013_bib28","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/hep4.1428","article-title":"Cardiovascular risk categories in patients with nonalcoholic fatty liver disease and the role of low-density lipoprotein cholesterol","volume":"3","author":"Labenz","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2023.08.013_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/eurheartj\/ehx662","article-title":"Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: mendelian randomization and meta-analysis of 279 013 individuals","volume":"39","author":"Lauridsen","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jceh.2023.08.013_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2016.10.040","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes","volume":"225","author":"Mantovani","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jceh.2023.08.013_bib31","first-page":"30992","article-title":"Association of hepatic steatosis with major adverse cardiovascular events, independent of coronary artery disease","volume":"S1542\u20133565","author":"Meyersohn","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.08.013_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4254\/wjh.v12.i6.323","article-title":"Non-alcoholic fatty liver disease is not independent risk factor for cardiovascular disease event: a cohort study","volume":"12","author":"Motamed","year":"2020","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2023.08.013_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245762","article-title":"Outcomes of NAFLD and MAFLD: results from a community-based, prospective cohort study","volume":"16","author":"Niriella","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2023.08.013_bib34","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2214\/AJR.13.11367","article-title":"Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications","volume":"202","author":"Pickhardt","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jceh.2023.08.013_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004973","article-title":"Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study","volume":"4","author":"Pisto","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jceh.2023.08.013_bib36","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2023.08.013_bib37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/jgh.14856","article-title":"Non-alcoholic fatty liver disease and the incidence of myocardial infarction: a cohort study","volume":"35","author":"Sinn","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.08.013_bib38","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jceh.2023.08.013_bib39","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/hep.28390","article-title":"Noninvasive fatty liver markers predict liver disease mortality in the U.S. population","volume":"63","author":"Unalp-Arida","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.08.013_bib40","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1148\/radiol.2019181793","article-title":"Association between nonalcoholic fatty liver disease at CT and coronary microvascular dysfunction at myocardial perfusion PET\/CT","volume":"291","author":"Vita","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2023.08.013_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2337\/dc17-1590","article-title":"Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission","volume":"41","author":"Wild","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jceh.2023.08.013_bib42","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/hep.28253","article-title":"Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: a prospective cohort study","volume":"63","author":"Wong","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.08.013_bib43","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/jvh.13361","article-title":"Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B","volume":"27","author":"Wong","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jceh.2023.08.013_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/STROKEAHA.120.030433","article-title":"Severity of nonalcoholic fatty liver disease and risk of future ischemic stroke events","volume":"52","author":"Xu","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jceh.2023.08.013_bib45","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jacc.2016.01.070","article-title":"Nonalcoholic fatty liver disease and incident cardiac events: the multi-ethnic study of atherosclerosis","volume":"67","author":"Zeb","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jceh.2023.08.013_bib46","first-page":"153","article-title":"Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study","volume":"13","author":"Zhou","year":"2012","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.jceh.2023.08.013_bib47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jceh.2023.08.013_bib48","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2023.08.013_bib49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.08.013_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/124958","article-title":"Independent association between nonalcoholic fatty liver disease and cardiovascular disease: a systematic review and meta-analysis","volume":"2013","author":"Lu","year":"2013","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jceh.2023.08.013_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jceh.2020.04.018","article-title":"The association between nonalcoholic fatty liver disease and risk of cardiovascular disease, stroke, and extrahepatic cancers","volume":"11","author":"Veracruz","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2023.08.013_bib52","article-title":"Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2023.08.013_bib53","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.dsx.2016.12.033","article-title":"Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: a systematic review and meta-analysis","volume":"11","author":"Mahfood Haddad","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jceh.2023.08.013_bib54","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/HEP.0000000000000286","article-title":"The association between hepatic steatosis and incident cardiovascular disease, cancer, and all-cause mortality in a US multicohort study","volume":"77","author":"Ahmed","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.08.013_bib55","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.numecd.2023.01.013","article-title":"Comparison of cardiovascular mortality between MAFLD and NAFLD: a cohort study","volume":"33","author":"Yoo","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jceh.2023.08.013_bib56","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3390\/nu14122361","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with the risk of incident cardiovascular disease: a prospective cohort study in Xinjiang","volume":"14","author":"Guo","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2023.08.013_bib57","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688323006989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688323006989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:10:50Z","timestamp":1760854250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688323006989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0973688323006989"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2023.08.013","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Independent Association of Non-alcoholic Fatty Liver Disease With Incident Cardiovascular Disease: A GRADE Evaluation of the Evidence Through a Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2023.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101277"}}